Nucleoside reverse transcriptase inhibitors appear to be neuroprotective, thus lowering the incidence of Alzheimer dementia.

The two active substances are antivirals that inhibit HIV reverse transcriptase through incorporation into the viral DNA, ...

Doctor Jayakrishna Ambati and his research team have begun work on a new drug called K9 which could treat and prevent ...

It’s estimated that over 10 million people around the world develop Alzheimer’s disease annually,” according to Dr.

Mike McCune, MD, PhD, head of the HIV Frontiers Program at the Gates Foundation, delivered an upbeat message at the ASGCT annual conference in New Orleans last week, showcasing the progress being made ...

The protective benefit of ART against viral blips was observed among patients who initiated treatment up to 2 years after HIV acquisition.

Younger patients with grade 3 oligodendroglioma have fewer molecular abnormalities and longer survival than older patients, a ...

Arbor Biotechnologies, Inc., a biotechnology company discovering and developing the next generation of genetic medicines, today announced the appointment of Don Haut, Ph.D., as Chief Business Officer.

Human immunodeficiency virus or HIV is a virus that makes your immune system so weak that it becomes hard for it to fight off ...

Nucleoside reverse transcriptase inhibitor; PI: Protease inhibitor; PK: Pharmacokinetics; RPV: Rilpivirine. Data taken from [10,33–38]. Blake Max's spouse is employed as a regional medical ...

Researchers have traced where and when the HIV protective mutation arose but also how it gave northern European ancestors a competitive advantage against ancient diseasesA genetic mutation in a ...